Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-03

Clinical Trial Update: Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating risperidone and its active metabolite (9-hydroxy risperidone) when risperidone is administered from a polyurethane impl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 9-Hydroxyrisperidone (9-hydroxy risperidone)
  • Risperdal (risperidone)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED